Shire

Shire

Global Innovator in Specialty Biopharmaceuticals.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
*

$5.9b

Valuation: $5.9b

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20152016201720182019
Revenues00000000000000000000
% growth---100 %-
EBITDA00000000000000000000
% EBITDA margin--100 %100 %100 %
Profit00000000000000000000
EV00000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x
R&D budget00000000000000000000
R&D % of revenue--143100 %--

Source: Company filings or news article

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit

Investments by Shire

Edit
Foresight Biotherapeutics
ACQUISITION by Shire Aug 2015
ArmaGen Technologies
ACQUISITION by JCR Pharmaceuticals Mar 2020
New River Pharmaceuticals
ACQUISITION by Shire Apr 2007
Naurex
ACQUISITION by Allergan Jul 2015
Lumena Pharmaceuticals
ACQUISITION by Shire May 2014
ViroPharma
ACQUISITION by Shire Nov 2013
Movetis
ACQUISITION by Shire Aug 2010
Meritage Pharma
ACQUISITION by Shire Feb 2015
View 12 more